Dashboard
Manage Tickers

OTLK Outlook Therapeutics, Inc.

Nasdaq outlooktherapeutics.com


$ 1.31 $ -0.03 (-2.24 %)    

Friday, 17-Oct-2025 18:11:21 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.31
$ 1.32
$ 1.26 x 150
$ 1.37 x 60
$ 1.27 - $ 1.39
$ 0.79 - $ 6.98
1,264,725
na
58.19M
$ 1.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-Q
4 12-27-2024 09-30-2024 10-K
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 02-14-2024 12-31-2023 10-Q
8 12-22-2023 09-30-2023 10-K
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-Q
12 12-29-2022 09-30-2022 10-K
13 08-10-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 02-14-2022 12-31-2021 10-Q
16 12-23-2021 09-30-2021 10-K
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-Q
20 12-23-2020 09-30-2020 10-K
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 02-14-2020 12-31-2019 10-Q
24 12-19-2019 09-30-2019 10-K
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 02-14-2019 12-31-2018 10-Q
28 12-18-2018 09-30-2018 10-K
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-Q
32 12-29-2017 09-30-2017 10-K
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-14-2017 12-31-2016 10-Q
36 12-29-2016 09-30-2016 10-K
37 08-15-2016 06-30-2016 10-Q
38 06-27-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-neutral-on-outlook-therapeutics-maintains-1-price-target
HC Wainwright & Co. Reiterates Neutral on ...
09/30/2025 11:41:03

HC Wainwright & Co. analyst Douglas Tsao reiterates Outlook Therapeutics (NASDAQ:OTLK) with a Neutral and maintains $1 p...

ascendiant-capital-maintains-buy-on-outlook-therapeutics-lowers-price-target-to-8
Ascendiant Capital Maintains Buy on Outloo...
09/22/2025 09:30:42

Ascendiant Capital analyst Edward Woo maintains Outlook Therapeutics (NASDAQ:OTLK) with a Buy and lowers the price target fr...

outlook-therapeutics-requests-fda-meeting-to-clarify-confirmatory-evidence-requirements-for-ons-5010-wet-amd-biologics-license-application
Outlook Therapeutics Requests FDA Meeting ...
09/02/2025 12:36:17

Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizuma...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/29/2025 17:05:57

guggenheim-downgrades-outlook-therapeutics-to-neutral
Guggenheim Downgrades Outlook Therapeutics...
08/29/2025 16:51:29

Guggenheim analyst Eddie Hickman downgrades Outlook Therapeutics (NASDAQ:OTLK) from Buy to Neutral.

hc-wainwright--co-downgrades-outlook-therapeutics-to-neutral-announces-1-price-target
HC Wainwright & Co. Downgrades Outlook The...
08/29/2025 12:47:27

HC Wainwright & Co. analyst Douglas Tsao downgrades Outlook Therapeutics (NASDAQ:OTLK) from Buy to Neutral and announces...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/29/2025 12:07:49

chardan-capital-maintains-neutral-on-outlook-therapeutics-maintains-3-price-target
Chardan Capital Maintains Neutral on Outlo...
08/28/2025 20:39:49

Chardan Capital analyst Daniil Gataulin maintains Outlook Therapeutics (NASDAQ:OTLK) with a Neutral and maintains $3 price t...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 17:06:35

nasdaq-surges-100-points-dollar-general-earnings-beat-views
Nasdaq Surges 100 Points; Dollar General E...
08/28/2025 16:54:43

fda-rejects-outlook-therapeutics-eye-drug-for-second-time
FDA Rejects Outlook Therapeutics Eye Drug ...
08/28/2025 15:15:40

Outlook Therapeutics shares fall after the FDA rejects its ONS-5010 wet AMD drug application, citing insufficient efficacy evid...

us-stocks-mixed-nvidia-posts-upbeat-earnings
US Stocks Mixed; Nvidia Posts Upbeat Earnings
08/28/2025 14:27:31

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 12:08:20

fda-declines-outlook-therapeutics-wet-amd-drug-application-in-present-form-company-pursues-approval-path-plans-eu-market-growth
FDA Declines Outlook Therapeutics' Wet AMD...
08/28/2025 10:33:41

FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLAOutlook Therapeutics plans to work with FDA to address th...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/27/2025 21:06:08

why-mongodb-shares-are-trading-higher-by-31-here-are-20-stocks-moving-premarket
Why MongoDB Shares Are Trading Higher By 3...
08/27/2025 10:05:03

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 21:08:52

chardan-capital-maintains-neutral-on-outlook-therapeutics-maintains-3-price-target
Chardan Capital Maintains Neutral on Outlo...
08/15/2025 12:07:01

Chardan Capital analyst Daniil Gataulin maintains Outlook Therapeutics (NASDAQ:OTLK) with a Neutral and maintains $3 price t...

outlook-therapeutics-says-fda-pdufa-goal-date-for-ons-5010-set-for-august-27-2025
Outlook Therapeutics Says FDA PDUFA Goal D...
08/14/2025 12:45:18

outlook-therapeutics-q3-adj-eps-044-misses-039-estimate-sales-1505m-miss-1663m-estimate
Outlook Therapeutics Q3 Adj. EPS $(0.44) M...
08/14/2025 12:23:24

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION